Machine learning-powered antibiotics phenotypic drug discovery

The present study explores use of phenotypic readouts beyond classical antibacterial growth inhibition adopting a combined multiparametric high content screening and genomic approach. The proposed approach could be profitably applied to a broader range of diseases amenable to phenotypic drug discovery.

Article: Nature